Inari Medical's upward revision of its FY24 revenue forecast not only surpasses the analyst estimates but also shows a significant improvement from its previous forecast. This indicates a strong growth trajectory and positive business momentum, which is likely to instill investor confidence and potentially drive the stock price up in the short term.